Latest Breaking News On - Jeannette potts - Page 1 : vimarsana.com

uniQure Inc : uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

uniQure Inc : uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandUnited statesNew yorkMatt kapustaJeannette pottsTom maloneLos angelesApic bioChiara russoMariae cantorWalid abi saabDavid cervenyAbbott laboratoriesNovo nordiskGroup viceAmerican society of gene

UniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

~ Announced encouraging interim analysis data from ongoing Phase I/II clinical trial of AMT-130 in Huntington’s disease showing preservation of function compared to baseline and clinical benefits.

Noord hollandNew yorkUnited statesJeannette pottsLos angelesChiara russoTom maloneWalid abi saabDavid cervenyMatt kapustaMariae cantorApic bioCounsel at millennium pharmaceuticalsEuropean unionTakeda pharmaceuticalsNovo nordisk

uniQure Inc : uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

uniQure Inc : uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandJeannette pottsChiara russoTom maloneChief legalCompliance officerGrant dateNasdaq listing ruleQure contacts

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass. and AMSTERDAM, June 16, 2023 (GLOBE NEWSWIRE) uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced

Noord hollandJeannette pottsTom maloneChiara russoChief legalCompliance officerGrant dateNasdaq listing ruleQure contacts

UniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass. and AMSTERDAM, June 16, 2023 uniQure N.V. , a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the grant. | June 16, 2023

Noord hollandChiara russoJeannette pottsChief legalCompliance officerGrant dateNasdaq listing ruleQure contacts